articleThe LancetJun 30, 2011Closed access

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

Joslin Diabetes Center · University of South Florida · +16 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

599
total citations
FWCI
31.69
Percentile
100%
References
34
Citations per year

Authors

19

Topics & keywords

Keywords
  • Abatacept
  • Medicine
  • Placebo
  • Double blind
  • Type 2 diabetes
  • Internal medicine
  • Diabetes mellitus
  • Endocrinology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding